Immunoglobulin Fragments
"Immunoglobulin Fragments" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Partial immunoglobulin molecules resulting from selective cleavage by proteolytic enzymes or generated through PROTEIN ENGINEERING techniques.
Descriptor ID |
D007128
|
MeSH Number(s) |
D12.644.541.500 D12.776.124.486.485.680 D12.776.124.790.651.680 D12.776.377.715.548.680
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin Fragments".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin Fragments".
This graph shows the total number of publications written about "Immunoglobulin Fragments" by people in this website by year, and whether "Immunoglobulin Fragments" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 | 2004 | 1 | 0 | 1 | 2006 | 0 | 1 | 1 | 2008 | 1 | 0 | 1 | 2010 | 1 | 1 | 2 | 2011 | 0 | 1 | 1 | 2012 | 2 | 1 | 3 | 2013 | 1 | 0 | 1 | 2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoglobulin Fragments" by people in Profiles.
-
Holguin F. Biological Treatments for Eosinophilic Asthma Enter the Airways. Am J Respir Crit Care Med. 2018 09 01; 198(5):551-552.
-
Lavonas EJ, Benson BE, Seifert SA. Failure to develop sensitization despite repeated administration of ovine fab snake antivenom: update of a single-patient, multicenter case series. Ann Emerg Med. 2013 Mar; 61(3):371-2.
-
Gleason MK, Verneris MR, Todhunter DA, Zhang B, McCullar V, Zhou SX, Panoskaltsis-Mortari A, Weiner LM, Vallera DA, Miller JS. Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production. Mol Cancer Ther. 2012 Dec; 11(12):2674-84.
-
Lavonas EJ. Antivenoms for snakebite: design, function, and controversies. Curr Pharm Biotechnol. 2012 Aug; 13(10):1980-6.
-
Schaeffer TH, Khatri V, Reifler LM, Lavonas EJ. Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis. Acad Emerg Med. 2012 Feb; 19(2):121-31.
-
Kirchdoerfer RN, Garner AL, Flack CE, Mee JM, Horswill AR, Janda KD, Kaufmann GF, Wilson IA. Structural basis for ligand recognition and discrimination of a quorum-quenching antibody. J Biol Chem. 2011 May 13; 286(19):17351-8.
-
Yin S, Kokko J, Lavonas E, Mlynarchek S, Bogdan G, Schaeffer T. Factors associated with difficulty achieving initial control with crotalidae polyvalent immune fab antivenom in snakebite patients. Acad Emerg Med. 2011 Jan; 18(1):46-52.
-
Kahook MY, Ammar DA. In vitro effects of antivascular endothelial growth factors on cultured human trabecular meshwork cells. J Glaucoma. 2010 Sep; 19(7):437-41.
-
Bebarta VS, Ferre RM, Peck M. Tracheal intubation prevented with administration of Fab antivenom after severe crotaline envenomation. J Emerg Med. 2010 Jul; 39(1):e81-3.
-
Smulski C, Labovsky V, Levy G, Hontebeyrie M, Hoebeke J, Levin MJ. Structural basis of the cross-reaction between an antibody to the Trypanosoma cruzi ribosomal P2beta protein and the human beta1 adrenergic receptor. FASEB J. 2006 Jul; 20(9):1396-406.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|